$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000166607120000128 Filed on May 11, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q1
Revenue	$28.22M	$45.51M	$35.99M
YoY Change	-42.08%	26.46%	10.01%
Cost Of Revenue	$16.81M	$26.14M	$19.00M
YoY Change	-39.14%	37.58%	-11.3%
Gross Profit	$11.41M	$19.37M	$16.98M
YoY Change	-45.95%	14.08%	50.4%
Gross Profit Margin	40.43%	42.56%	47.18%
Selling, General & Admin	$22.14M	$21.71M	$16.34M
YoY Change	14.2%	32.9%	10.4%
% of Gross Profit	194.03%	112.09%	96.21%
Research & Development	$3.966M	$3.851M	$2.941M
YoY Change	42.56%	30.94%	-14.98%
% of Gross Profit	34.76%	19.88%	17.32%
Depreciation & Amortization	$1.550M	$2.349M	$961.0K
YoY Change	47.62%	144.43%	5.6%
% of Gross Profit	13.58%	12.13%	5.66%
Operating Expenses	$26.11M	$25.56M	$19.28M
YoY Change	17.75%	32.6%	5.59%
Operating Profit	-$19.74M	-$11.93M	-$6.501M
YoY Change	260.05%	83.49%	-33.78%
Interest Expense	-$20.00K	-$1.600M	-$300.0K
YoY Change	-94.12%	433.33%	-97.25%
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$1.602M	$187.0K
YoY Change	-98.05%	-956.68%	-101.83%
Pretax Income	-$19.76M	-$13.53M	-$6.314M
YoY Change	203.5%	114.3%	-68.52%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$19.76M	-$13.53M	-$6.314M
YoY Change	203.5%	114.3%	-68.52%
Net Earnings / Revenue	-70.01%	-29.73%	-17.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$730.0K	-$506.2K	-$280.4K
COMMON SHARES
Basic Shares Outstanding	26.97M shares	26.70M shares	22.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.40M	$102.2M	$36.40M
YoY Change	202.77%	180.77%	-59.47%
Cash & Equivalents	$98.37M	$102.2M	$36.43M
Short-Term Investments
Other Short-Term Assets	$6.500M	$6.100M	$25.30M
YoY Change	-59.12%	-75.89%	583.78%
Inventory
Prepaid Expenses
Receivables	$36.57M	$57.67M	$53.25M
Other Receivables	$5.007M	$4.066M	$2.328M
Total Short-Term Assets	$146.4M	$170.0M	$117.3M
YoY Change	26.98%	44.97%	-13.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.98M	$13.09M	$11.35M
YoY Change	9.15%	15.28%	54.16%
Goodwill
YoY Change
Intangibles	$407.0K	$404.0K	$367.0K
YoY Change	10.3%	10.08%	2.23%
Long-Term Investments
YoY Change
Other Assets	$1.701M	$1.962M	$1.369M
YoY Change	32.79%	43.32%	38.56%
Total Long-Term Assets	$36.64M	$36.04M	$29.17M
YoY Change	29.66%	23.54%	34.36%
TOTAL ASSETS
Total Short-Term Assets	$146.4M	$170.0M	$117.3M
Total Long-Term Assets	$36.64M	$36.04M	$29.17M
Total Assets	$183.0M	$206.1M	$146.5M
YoY Change	27.5%	40.7%	-7.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.177M	$1.146M	$1.896M
YoY Change	-2.89%	-39.56%	6.34%
Accrued Expenses	$3.270M	$3.003M	$3.743M
YoY Change	-18.49%	-19.77%	-4.47%
Deferred Revenue	$969.0K	$603.0K	$574.0K
YoY Change	144.08%	5.05%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$24.00K	$24.00K	$22.00K
YoY Change	9.09%	9.09%	-99.91%
Total Short-Term Liabilities	$42.46M	$58.41M	$49.56M
YoY Change	-26.06%	17.86%	-38.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$7.000K	$46.69M
YoY Change	-100.0%	-99.99%	41.94%
Other Long-Term Liabilities	$10.10M	$9.300M
YoY Change
Total Long-Term Liabilities	$0.00	$7.000K	$99.29M
YoY Change	-100.0%	-99.99%	172.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.46M	$58.41M	$49.56M
Total Long-Term Liabilities	$0.00	$7.000K	$99.29M
Total Liabilities	$52.57M	$67.72M	$148.8M
YoY Change	-65.96%	-54.5%	26.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$371.9M	-$352.2M	-$327.8M
YoY Change	11.25%	7.43%	13.62%
Common Stock	$499.7M	$487.9M	$373.4M
YoY Change	31.92%	30.68%	13.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$130.5M	$138.4M	$47.18M
YoY Change
Total Liabilities & Shareholders Equity	$183.0M	$206.1M	$146.5M
YoY Change	27.5%	40.7%	-7.19%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$19.76M	-$13.53M	-$6.314M
YoY Change	203.5%	114.3%	-68.52%
Depreciation, Depletion And Amortization	$1.550M	$2.349M	$961.0K
YoY Change	47.62%	144.43%	5.6%
Cash From Operating Activities	-$4.230M	-$3.406M	-$1.483M
YoY Change	183.89%	129.67%	1547.78%
INVESTING ACTIVITIES
Capital Expenditures	-$1.950M	$492.0K	$1.492M
YoY Change	-38.68%	-67.02%	256.94%
Acquisitions	$0.00	$0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.950M	-$1.437M	-$1.981M
YoY Change	-38.68%	-27.46%	149.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.145M	$173.0K
YoY Change		1717.92%	-99.75%
Debt Paid & Issued, Net		$6.000K	$5.000K
YoY Change		20.0%	-80.77%
Cash From Financing Activities	2.270M	$3.139M	$162.0K
YoY Change	-125.08%	1837.65%	-99.77%
NET CHANGE
Cash From Operating Activities	-4.230M	-$3.406M	-$1.483M
Cash From Investing Activities	-1.950M	-$1.437M	-$1.981M
Cash From Financing Activities	2.270M	$3.139M	$162.0K
Net Change In Cash	-3.910M	-$2.292M	-$3.182M
YoY Change	-71.5%	-27.97%	-104.64%
FREE CASH FLOW
Cash From Operating Activities	-$4.230M	-$3.406M	-$1.483M
Capital Expenditures	-$1.950M	$492.0K	$1.492M
Free Cash Flow	-$2.280M	-$3.898M	-$2.975M
YoY Change	-234.91%	31.03%	485.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22466000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25664000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22466000	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25664000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-38386
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2020Q1	dei	City Area Code CityAreaCode	(888)
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	792-5802
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102174000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	129000	USD
CY2020Q1	dei	Trading Symbol TradingSymbol	CDLX
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26967594	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104458000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	121000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81452000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57668000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3908000	USD
CY2020Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4066000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5783000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6013000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	195730000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	170042000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14290000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13085000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9421000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	389000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	404000	USD
CY2019Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3815000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3789000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	8383000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	7375000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1706000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1962000	USD
CY2019Q4	us-gaap	Assets Assets	224313000	USD
CY2020Q1	us-gaap	Assets Assets	206078000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1229000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1146000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8186000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5023000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6018000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3003000	USD
CY2019Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	41956000	USD
CY2020Q1	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	31049000	USD
CY2019Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	19861000	USD
CY2020Q1	cdlx	Customer Incentive Liability CustomerIncentiveLiability	14223000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1127000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	603000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3337000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	24000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	24000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78401000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	58408000	USD
CY2019Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2632000	USD
CY2020Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9305000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	81046000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	67720000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	480578000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	487903000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1312000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2609000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338631000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-352162000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	138358000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	224313000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	206078000	USD
CY2019Q1	us-gaap	Revenues Revenues	35988000	USD
CY2020Q1	us-gaap	Revenues Revenues	45509000	USD
CY2019Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	19004000	USD
CY2020Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	26138000	USD
CY2019Q1	cdlx	Delivery Costs DeliveryCosts	3246000	USD
CY2020Q1	cdlx	Delivery Costs DeliveryCosts	3406000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9337000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10968000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2941000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3851000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7000000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10744000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	961000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2331000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	42489000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	57438000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11929000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-304000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1886000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	187000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6501000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	284000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	491000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1602000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1923000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	509000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6314000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13531000	USD
CY2019Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	653000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1008000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-6314000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6314000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13531000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22503000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26725000	shares
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-6314000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-372000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1297000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6686000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12234000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3145000	USD
CY2020Q1	cdlx	Stock Issued During Period Shares Warrants Exercised In Period StockIssuedDuringPeriodSharesWarrantsExercisedInPeriod	0	shares
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4180000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1297000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	138358000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	51975000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	173000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1715000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-372000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-6314000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	47177000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-6314000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	250000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1477000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	961000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2331000	USD
CY2019Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	27000	USD
CY2020Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	24000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	879000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1708000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4740000	USD
CY2019Q1	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	1157000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22149000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1173000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4125000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	485000	USD
CY2020Q1	us-gaap	Interest Paid InterestPaid	16000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-691000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	252000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1770000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6988000	USD
CY2019Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-4287000	USD
CY2020Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-10908000	USD
CY2019Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	3741000	USD
CY2020Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-5638000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1483000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3406000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1492000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	492000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2020Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23000	USD
CY2019Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	489000	USD
CY2020Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	922000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1981000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1437000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	173000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3145000	USD
CY2019Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6000	USD
CY2020Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	162000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3139000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-588000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3182000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2292000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59870000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56688000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102295000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36428000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102174000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	20260000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	121000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56688000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102295000	USD
CY2019Q1	us-gaap	Interest Paid InterestPaid	463000	USD
CY2019Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	1146000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	397000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1383000	USD
CY2020Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	13000	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, income taxes, stock-based compensation, allowance for doubtful accounts, income tax valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div>
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	500000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	700000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1500000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	169000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	255000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	250000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1477000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	349000	USD
CY2019Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	22600000	USD
CY2020Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	22300000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35988000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45509000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1027000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	297000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	112000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	936000	USD
CY2020Q1	cdlx	Lease Weighted Average Discount Rate Percent LeaseWeightedAverageDiscountRatePercent	0.034
CY2020Q1	cdlx	Lease Weighted Average Remaining Lease Term LeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2805000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3291000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3189000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1880000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1807000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	611000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13583000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	941000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12642000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3040000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2759000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2808000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1847000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1807000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	611000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	12872000	USD
CY2020Q1	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1875000	shares
CY2018Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Remaining For Available For Issuance SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesRemainingForAvailableForIssuance	61247	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1345631	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1327352	shares
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1708000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4125000	USD
CY2020Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	100000	USD
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1000000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.99
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	161000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.53
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	21.62
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	28.96
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	837000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.66
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10140000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	659000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.25
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8372000	USD
CY2020Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	34.96
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	700000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2100000	USD
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15200000	USD
CY2020Q1	cdlx	Classof Warrantor Right Exercised ClassofWarrantorRightExercised	644365	shares
CY2018Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	15877000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	8383000	USD
CY2019Q1	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	1157000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-653000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-1008000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	14067000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	7375000	USD
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q1	cdlx	Adjusted Contribution AdjustedContribution	17637000	USD
CY2020Q1	cdlx	Adjusted Contribution AdjustedContribution	20379000	USD
CY2019Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	653000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1008000	USD
CY2019Q1	cdlx	Delivery Costs DeliveryCosts	3246000	USD
CY2020Q1	cdlx	Delivery Costs DeliveryCosts	3406000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9337000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10968000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2941000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3851000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7000000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10744000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	961000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2331000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	187000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1602000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6314000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13531000	USD
CY2019Q1	us-gaap	Revenues Revenues	35988000	USD
CY2020Q1	us-gaap	Revenues Revenues	45509000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14290000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13085000	USD

Files In Submission

Name	View Source	Status
0001666071-20-000128-index-headers.html	Edgar Link	pending
0001666071-20-000128-index.html	Edgar Link	pending
0001666071-20-000128.txt	Edgar Link	pending
0001666071-20-000128-xbrl.zip	Edgar Link	pending
cardlytics_logoa28.jpg	Edgar Link	pending
cdlx-20200331.xsd	Edgar Link	pending
cdlx-20200331_cal.xml	Edgar Link	unprocessable
cdlx-20200331_def.xml	Edgar Link	unprocessable
cdlx-20200331_lab.xml	Edgar Link	unprocessable
cdlx-20200331_pre.xml	Edgar Link	unprocessable
cdlxform10-q2020q1.htm	Edgar Link	pending
cdlxform10-q2020q1ex101.htm	Edgar Link	pending
cdlxform10-q2020q1ex311.htm	Edgar Link	pending
cdlxform10-q2020q1ex312.htm	Edgar Link	pending
cdlxform10-q2020q1ex321.htm	Edgar Link	pending
cdlxform10-q2020q1_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2020 Q2 Form 10-Q Financial Statement

#000166607120000128 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2020 Q2 Form 10-Q Financial Statement

#000166607120000128 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx